Share
The National Institute of Mental Health has awarded a $3.1 million grant to Virginia Commonwealth University researchers to study whether evidence-based mental health programs in schools continue after research support is removed.
Share
Sweden, famously, decided against instituting a COVID-19 lockdown. How that policy played out is the subject of a new analysis involving a University of Virginia School of Medicine researcher.
Share
In response to the COVID-19 pandemic, Virginia Tech researchers and scientists initiated numerous research projects in an effort to support the local community and to affect humanity on a global scale.
Share
Virginia Tech researchers studying how a usually benign virus attacks the human heart with sometimes fatal consequences determined that the virus disrupts the heart’s electrical system – and with dual impacts not previously recognized.
Share
Carla Finkielstein, a cancer researcher and an associate professor of biological sciences in Virginia Tech’s College of Science, will join the Fralin Biomedical Research Institute at VTC on July 1.
Share
The messenger may have been murdered en route, or slave masters may have suppressed the news to ensure the harvesting of one more crop.
Share
As the COVID-19 pandemic sweeps across the globe, people are beginning to understand, at a very personal level, the ways in which infectious diseases can devastate life. But disease outbreaks are not confined to just humans or to life on land.
Share
Gov. Ralph Northam today announced 26 small technology-based businesses and four universities will receive incentive grants to commercialize their research in clean energy, cybersecurity, data analytics, life sciences, and unmanned systems.
Share
A total of $52,140 in funding for faculty-student summer research projects has been awarded to 12 Bridgewater College students who will conduct research under the mentorship of a faculty member throughout the summer.
Share
UVA Health and UVA Children’s Hospital are increasing access to the latest food allergy clinical trials and expanding their cutting-edge food-allergy research.
Independent media doesn’t belong to billionaires or big companies – it belongs to you. If you find value in our work, please consider a contribution.